By Cancer Treatment Centers of America®

Advances in treatment options are improving survival rates and quality-of-life outcomes for metastatic breast cancer patients. “We have many more treatment options than we’ve ever had before,” says Dennis Citrin, MD, PhD, Medical Oncologist at Cancer Treatment Centers of America in Chicago.

READ MORE about why Dr. Citrin says the science of oncology is light years ahead of where it was 30-40 years ago.

About Dennis Citrin, MD, PhD
Dr. Dennis Citrin is a board-certified medical oncologist with more than three decades of experience. His practice is exclusively devoted to patients with breast cancer. Dr. Citrin works with a team of experts to help patients fight breast cancer at Cancer Treatment Centers of America®(CTCA) near Chicago. Dr. Citrin earned a Bachelor of Medicine degree (MBCHB), which is equivalent to a medical degree (MD), from the University of Glasgow in Scotland. He then completed a residency in internal medicine at the university. Following his residency, he completed three years of breast cancer research, leading to a PhD. Dr. Citrin was then awarded a Medical Research Council fellowship in cancer medicine, which brought him to the University of Wisconsin-Madison, where he completed a fellowship in human oncology

About Cancer Treatment Centers of America®
Cancer Treatment Centers of America® (CTCA) is a national network of five hospitals that serves adult patients who are fighting cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, with evidence-informed supportive therapies designed to help patients physically and emotionally by enhancing their quality of life while managing side effects both during and after treatment.  Stay up to date on all things CTCA! Be sure to follow them on FacebookInstagramTwitterPinterestLinkedIn and YouTube or call 1-800-227-3207 for more information.

Menu